Resonance Deal to distribute Diabetic Retinopathy AI tool
Filed with ASX · · 3 pages · English
Earlier from Resonance Health
- Appointment of CEO
- RHT Develops new assessment for the screening of NASH
- Resonance Health contracted for new clinical trial
- FerriScan contracted for two new Clinical Trials
- Multi Centre testing commences for AI solution
Later from Resonance Health
- Additional Info. in relation to 4 May 2018 announcement
- Alliance Partner Agreement with Blackford Analysis
- TGA, CE Mark clearance for A.I. Solution FerriSmart
- Resonance Health contracted for two new clinical trials
- Additional Information on Announcement Dated 23 August 2018
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health